The estimated Net Worth of Hubert C Chen is at least 1.63 千$ dollars as of 20 May 2021. Hubert Chen owns over 3,289 units of Metacrine stock worth over 1,628$ and over the last 10 years Hubert sold MTCR stock worth over 0$.
Hubert has made over 1 trades of the Metacrine stock since 2021, according to the Form 4 filled with the SEC. Most recently Hubert bought 3,289 units of MTCR stock worth 11,840$ on 20 May 2021.
The largest trade Hubert's ever made was buying 3,289 units of Metacrine stock on 20 May 2021 worth over 11,840$. On average, Hubert trades about 470 units every 0 days since 2014. As of 20 May 2021 Hubert still owns at least 3,289 units of Metacrine stock.
You can see the complete history of Hubert Chen stock trades at the bottom of the page.
Hubert's mailing address filed with the SEC is C/O METACRINE, INC., 3985 SORRENTO VALLEY BLVD., SUITE C, SAN DIEGO, CA, 92121.
Over the last 4 years, insiders at Metacrine have traded over 5,582,700$ worth of Metacrine stock and bought 11,645,167 units worth 119,461,162$ . The most active insiders traders include Forest Baskett、Scott D Sandell、Anthony A. Jr. Florence. On average, Metacrine executives and independent directors trade stock every 24 days with the average trade being worth of 237,397$. The most recent stock trade was executed by Michael York on 26 January 2023, trading 107,054 units of MTCR stock currently worth 43,892$.
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Metacrine executives and other stock owners filed with the SEC include: